Cetera Investment Advisers Has $43,000 Holdings in Aurora Cannabis Inc. (NASDAQ:ACB)

Cetera Investment Advisers lowered its position in shares of Aurora Cannabis Inc. (NASDAQ:ACB) by 19.0% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,156 shares of the company’s stock after selling 2,385 shares during the quarter. Cetera Investment Advisers’ holdings in Aurora Cannabis were worth $43,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in ACB. SBI Securities Co. Ltd. bought a new stake in shares of Aurora Cannabis during the 4th quarter worth $31,000. Susquehanna Fundamental Investments LLC acquired a new position in Aurora Cannabis during the 4th quarter valued at $45,000. Edmond DE Rothschild Holding S.A. acquired a new position in Aurora Cannabis during the 4th quarter valued at $88,000. Wealthspire Advisors LLC acquired a new position in Aurora Cannabis during the 4th quarter valued at $149,000. Finally, Bulltick Wealth Management LLC acquired a new position in Aurora Cannabis during the 4th quarter valued at $150,000. Institutional investors and hedge funds own 47.63% of the company’s stock.

Aurora Cannabis Stock Down 1.7%

Aurora Cannabis stock opened at $5.21 on Tuesday. The company’s 50 day simple moving average is $4.70 and its 200 day simple moving average is $4.64. Aurora Cannabis Inc. has a fifty-two week low of $3.42 and a fifty-two week high of $7.20. The firm has a market capitalization of $292.87 million, a price-to-earnings ratio of 104.22 and a beta of 1.94. The company has a debt-to-equity ratio of 0.07, a current ratio of 3.30 and a quick ratio of 1.60.

Wall Street Analyst Weigh In

Separately, Atb Cap Markets raised shares of Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.